Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.
3.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
5.
6.
7.

Immunity and immunopathology to respiratory syncytial virus. The mouse model.

Openshaw PJ.

Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S59-62. Review.

PMID:
7551415
8.

Immune-mediated disease pathogenesis in respiratory syncytial virus infection.

Graham BS, Johnson TR, Peebles RS.

Immunopharmacology. 2000 Jul 25;48(3):237-47. Review.

PMID:
10960663
9.

The CD4 T cell response to respiratory syncytial virus infection.

Christiaansen AF, Knudson CJ, Weiss KA, Varga SM.

Immunol Res. 2014 Aug;59(1-3):109-17. doi: 10.1007/s12026-014-8540-1. Review.

PMID:
24838148
10.

Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

González PA, Bueno SM, Riedel CA, Kalergis AM.

Curr Med Chem. 2009;16(34):4609-25. Review.

PMID:
19903147
11.

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

Murphy BR, Hall SL, Kulkarni AB, Crowe JE Jr, Collins PL, Connors M, Karron RA, Chanock RM.

Virus Res. 1994 Apr;32(1):13-36. Review.

PMID:
8030364
12.

The pathogenesis of respiratory syncytial virus disease in childhood.

McNamara PS, Smyth RL.

Br Med Bull. 2002;61:13-28. Review.

PMID:
11997296
13.

Novel pathways in the pathogenesis of respiratory syncytial virus disease.

van Schaik SM, Welliver RC, Kimpen JL.

Pediatr Pulmonol. 2000 Aug;30(2):131-8. Review.

PMID:
10922135
14.

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

Crowe JE Jr.

Clin Infect Dis. 2001 Nov 15;33(10):1720-7. Epub 2001 Oct 5. Review.

PMID:
11595986
15.

Respiratory syncytial virus--viral biology and the host response.

Hacking D, Hull J.

J Infect. 2002 Jul;45(1):18-24. Review.

PMID:
12217726
16.

Immune responses and disease enhancement during respiratory syncytial virus infection.

Openshaw PJ, Tregoning JS.

Clin Microbiol Rev. 2005 Jul;18(3):541-55. Review.

17.

Current concepts on active immunization against respiratory syncytial virus for infants and young children.

Kneyber MC, Kimpen JL.

Pediatr Infect Dis J. 2002 Jul;21(7):685-96. Review.

PMID:
12237605
18.

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.

Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Chanock RM.

Virus Res. 1988 Aug;11(1):1-15. Review.

PMID:
2845680
19.

Identifying targets in the hunt for effective respiratory syncytial virus interventions.

Tayyari F, Hegele RG.

Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8. Review.

PMID:
22455493
20.

The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus.

Klein Klouwenberg P, Tan L, Werkman W, van Bleek GM, Coenjaerts F.

Crit Rev Immunol. 2009;29(6):531-50. Review.

PMID:
20121698

Supplemental Content

Support Center